Loading company…
Mable provides genomics-based telehealth services for migraine and neurological care.
Founded in 2019 and based in California, Mable provides genetic testing, biomarker analysis, online consultations, and personalized treatment for neurological conditions. In July 2022, it raised USD 3.2 million in seed funding led by Initialized Capital, with an individual investor, Arkitekt Ventures, and First In Capital participating.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in